China Universal Asset Management »

Gracell Biotechnologies shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Gracell Biotechnologies shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Gracell Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Gracell Biotechnologies held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gracell Biotechnologies by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $84k 8.4k 9.99
2023-09-30 $5.0k 1.7k 2.86
2023-06-30 $3.0k 893 3.36
2023-03-31 $2.0k 903 2.21
2022-12-31 $2.0k 678 2.95
2022-09-30 $2.0k 624 3.21

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Gracell Biotechnologies

OrbiMed Advisors
Tang Capital Management
Baker Bros. Advisors
Pentwater Capital Management
TIG Advisors
Alpine Associates Management
Octagon Capital Advisors
Bank of America Corporation
LMR Partners
Sphera Funds Management
MMCAP International Inc. SPC
Hudson Bay Capital Management
Marshall Wace
Millennium Management
CNH Partners

View all funds holding Gracell Biotechnologies